bioRxivCell Biology
Protective role of the deSUMOylating enzyme SENP3 in myocardial ischaemia-reperfusion injury
Abstract
Interruption of blood supply to the heart is a leading cause of death and disability. However, the molecular events that occur during heart ischaemia, and how these changes prime consequent cell death upon reperfusion, are poorly understood. Protein SUMOylation is a post-translational modification that has been strongly implicated in the protection of cells against a variety of stressors, including ischaemia-reperfusion. In particular, the SUMO2/3-specific protease SENP3 has emerged as an important determinant of cell survival after ischaemic infarct. Here, we used the Langendorff perfusion model to examine changes in the levels and localisation of SUMOylated target proteins and SENP3 in whole heart. We observed a 50% loss of SENP3 from the cytosolic fraction of hearts after preconditioning, a 90% loss after ischaemia and an 80% loss after ischaemia-reperfusion. To examine these effects further, we performed ischaemia and ischaemia-reperfusion experiments in the cardiomyocyte H9C2 cell line. Similar to whole hearts, ischaemia induced a decrease in cytosolic SENP3. Furthermore, shRNA-mediated knockdown of SENP3 led to an increase in the rate of cell death upon reperfusion. Together, our results indicate that cardiac ischaemia dramatically alter levels of SENP3 and suggest that this may a mechanism to promote cell survival after ischaemia-reperfusion in heart.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis via Paracrine Action
Z. Liu·bioRxiv·Jun 21, 2023
- Clearance of senescent cells during cardiac ischemia-reperfusion injury improves heart recovery following myocardial infarction
E. Dookun, A. Walaszczyk, … G. D. Richardson·bioRxiv·Apr 28, 2020
- Complement C3 interacts with cytochrome c to influence myocardial apoptosis during heart ischemia/reperfusion
Zhou Fang, Haekyung Lee, … Ming Zhang·bioRxiv·Mar 15, 2023
- Formate reduces ischemic injury in the male heart by increasing protein S-nitrosation
Haley Garbus, Raihan Kabir, … Mark Jeffrey Kohr·bioRxiv·Feb 26, 2026
- AN INTEGRATED HEART-ON-A-CHIP NAM RESOLVES DISTINCT CLINICAL PHENOTYPES OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
Khanh Tran, Ashley Roselynn Vincent, … Anna Grosberg·bioRxiv·Oct 29, 2026
- Ablation of GM3 Gangliosides in cardiomyocytes modestly impacts heart size but does not protect the murine heart against ischemia reperfusion injury
Yow Keat Tham, Daniel G. Donner, … Julie R. McMullen·bioRxiv·Jul 18, 2026